Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

Hepatology

Volumn 33, Issue 5, 2001, Pages 1080-1086

  Jonas, Sven ^a   Bechstein, Wolf O ^a   Steinmüller, Thomas ^a   Herrmann, Martin ^a   Radke, Cornelia ^a   Berg, Thomas ^a   Settmacher, Utz ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

EID: 0035028451     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.23561     Document Type: Article

References (28)

1. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
2. Therapy of primary hepatocellular carcinoma
3. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
4. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
5. Role of staging laparoscopy in the treatment of hepatic malignancy
6. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma
7. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy
8. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
9. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
10. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
11. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: A controlled, prospective, randomized trial
12. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience
13. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases
14. Needle-tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary?
15. Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients
16. Should hepatomas be treated with hepatic resection or transplantation?
17. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
18. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma
19. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
20. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors
21. Research toward safer resection of the cirrhotic liver
22. Is surgery for large hepatocellular carcinoma justified?
23. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis
24. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
25. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma
26. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma
27. Expression of vascular endothelial growth factor in human hepatocellular carcinoma